Bioceres Crop Solutions (BIOX) EBT (2016 - 2026)

Bioceres Crop Solutions has disclosed EBT across 11 years of filings, most recently posting -$14.1 million for Q1 2026.

• EBT for Q1 2026 came in at -$14.1 million, down 1075.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$243.1 million (down 3660.93% YoY), and the FY2025 annual result was -$57.6 million, down 620.18% from the prior year.
• EBT came in at -$14.1 million for Q1 2026 at Bioceres Crop Solutions, up from -$182.5 million in the prior quarter.
• In the past five years, EBT ranged from a high of $22.3 million in Q1 2023 to a low of -$182.5 million in Q4 2025.
• The 5-year median for EBT is -$4.4 million (2023), against an average of -$12.7 million.
• Across the five-year window, EBT surged 3084.05% in 2022 and tumbled 2599.68% in 2025, its largest moves.
• Bioceres Crop Solutions' EBT stood at -$8.4 million in 2022, then surged by 213.6% to $9.6 million in 2023, then decreased by 23.74% to $7.3 million in 2024, then sank by 2599.68% to -$182.5 million in 2025, then soared by 92.27% to -$14.1 million in 2026.
• The last three EBT figures came in at -$14.1 million (Q1 2026), -$182.5 million (Q4 2025), and -$5.4 million (Q3 2025), per Business Quant data.